CAMBIUM MEDICAL TECHNOLOGIES
Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of regenerative therapies derived from novel processed human platelets. Cambium is developing Elate Ocular a standardized, commercialized platelet derived biologic eye drop for dry eye syndrome (keratoconjunctivis sicca) as its first FDA approved therapy. Elate Ocular is an investigational drug and is not yet approved for sale in or outside the United States.
CAMBIUM MEDICAL TECHNOLOGIES
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2013-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.cambiumbio.com
Total Employee:
11+
Status:
Active
Contact:
+001 404-262-0905
Total Funding:
5.11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Receptos
Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.
Current Employees Featured
Founder
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Cambium Medical Technologies
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Cambium Medical Technologies
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Cambium Medical Technologies
Official Site Inspections
http://www.cambiumbio.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cambium Medical Technologies"
Cambium Bio | Regenerative Medicine Company
Cambium Bio Limited (ASX:CMB) is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue โฆSee details»
Cambium Bio | Regenerative Medicine Company
Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration.See details»
Cambium Bio - LinkedIn
Cambium Bio Successfully Closes A$3.0M Financing Round! Key Highlights: - Capital raising of A$3.0 million completed at A$0.4637 per share - Strong support from new strategic investor โฆSee details»
Cambium Bio | Regenerative Medicine Company
Stay informed about Cambium Bio's latest financial performance, corporate developments, and strategic initiatives. Access our recent financial reports, press releases, and investor โฆSee details»
Cambium Medical Technologies - Overview, News & Similar
Cambium Medical Technologies contact info: Phone number: (678) 860-3725 Website: www.cambiumbio.com What does Cambium Medical Technologies do? Founded in 2013 by โฆSee details»
Cambium Bio - Crunchbase Company Profile & Funding
Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of โฆSee details»
Company Cambium Bio Limited - MarketScreener.com
6 days ago Cambium Bio Limited: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Australian S.E.: CMB ...See details»
Cambium Bio 2025 Company Profile: Stock Performance
Mar 17, 2022 Cambium Bio General Information Description. Cambium Bio Ltd is a clinical-stage regenerative medicine company in Australia. It focuses on the development of biologics for โฆSee details»
Cambium Bio Limited (ASX: CMB) - Stock Analysis
Dec 13, 2024 Company profile for Cambium Bio Limited (ASX: CMB) with a description, list of executives, contact details and other key facts.See details»
Cambium Medical Technologies, LLC | VentureRadar
Similar Companies: Tasso USA Privately Held Tasso's lead product, Tasso OnDemand allows people to collect blood from the comfort and privacy of their home and mail the samples back โฆSee details»
Cambium Medical Technologies - Datanyze
Cambium Medical Technologies Profile and History . Founded in 2013 by four distinguished physician/scientists at Emory University, Atlanta, Georgia (USA)-Cambium is focused on the โฆSee details»
Cambium Medical Technologies - Craft
Cambium Medical Technologies has 1 employees at their 1 location and $5 m in total funding,. See insights on Cambium Medical Technologies including office locations, competitors, โฆSee details»
Cambium Bio Ltd, CMB:ASX profile - FT.com - Financial Times
6 days ago Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology โฆSee details»
Natural Products Testing โ Cambium Analytica
Cambium Analytica is a full-service provider of comprehensive analytical & product development services for natural products including food, dietary supplements & botanical products.See details»
Corporate Presentation (December 2024) - Cambium Bio
Dec 2, 2024See details»
Cambium Medical Technologies LLC (Cambium Medical โฆ
ไบ่งฃCambium Medical Technologies LLC (Cambium Medical Technologies LLC)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็1้กนไธดๅบ่ฏ๏ผ่ฏ็ฉ:CAM-101ใSee details»
Cambium Bio Limited Announces Board Changes
16 Goodhope, Paddington, NSW 2021 Ph: 1300 995 098 โข www.cambium.bio โข ABN 13 127 035 358 ASX Announcement 22 November 2024 Cambium Bio Limited Announces Board ChangesSee details»
Cambium - LinkedIn
Cambium Defense and Space Manufacturing El Segundo, Los Angeles, CA 5,243 followers Radically different materials company delivering better, faster, cost-effective defense hardware โฆSee details»
Cambium - Crunchbase Company Profile & Funding
Cambium develops biomaterials for fields such as defense, space transport, aerospace, and renewable energy. Leveraging the Deep Tech convergence between synthetic biology, โฆSee details»
Cambium Bio | Regenerative Medicine Company
While HPL has not yet been approved for therapeutic use, it has been extensively utilized as a supplement in cell culture processes. Aurarix® FD-HPL technology has been sub-licensed to โฆSee details»